You may be breathing into a breathalyzer at your next
checkup. The new "breathalyzer" technology is an advance in disease diagnosis.
The technique is currently under development at the University of
Wisconsin-Madison. It's a simple but very sensitive method used to distinguish
normal and disease-state glucose metabolism. Breath testing is an exciting
development in diagnostics because it is non-invasive and even more sensitive
than the blood-based assays.

Image Credit:
yourdictionary.com
The Science
Often, the process for disease detection is tedious,
complicated, and many times leaves the patient and the doctor with ambiguous
answers. Metabolomics
is a new area of research that studies and characterizes the small molecules
called metabolites found in an organism. Metabolomics allow scientists to look
at genotype- phenotype and genotype-environment relationships by observing how
a metabolome relates to the genotype of an organism, its physiology and its environment
(what it eats or breaths). The relationship between a metabolome and its
genotype or environment is critical information which can be used in many
fields including pharmacology, drug trials and screenings. Here is a video with more
information about this field.
Many diseases, including diabetes, cancer, and infections, alter
the body's metabolism in a distinctive way. Metabolic changes can be detected
by measuring the isotopic signature of carbon-containing metabolic byproducts
in the blood or breath. The ratio of the isotopes in the blood or breath
produces different patterns for a wide range of diseases. "Your body
changes its fuel source. When we're healthy we use the food that we eat," senior
author Fariba Assadi-Porter says. "When we get sick, the immune system
takes over the body and starts tearing apart proteins to make antibodies and
use them as an energy source." Scientists
have advanced methods of tracing metabolic pathways that are disturbed from
disease. When the body shifts from sugar to protein it engages different
biochemical pathways and causes changes in the carbon isotope. The changes can
be detected in exhaled carbon dioxide and analyzed for information on disease
identification, development or recovery.

Image Credit:
Wikipedia
The Study
The new study
on metabolomics was published in the February 2012 issue of the journal
Metabolism. Researchers from UWM studied mice with metabolic symptoms similar
to those seen in women with polycystic ovary syndrome (PCOS). PCOS affects
approximately 1 in 10 women by causing infertility, ovarian cysts, and
metabolic dysfunction. Unfortunately the disease can only be diagnosed after
puberty and only after ruling out many other diseases. The goal of this study
was to use the change in isotope ratio due to metabolic changes to identify the
earliest stages of a disease, which can be treated with diet and medication.
The mice were injected with glucose containing a single
atom of the heavier isotope carbon-13. This isotope allowed scientists to trace
which metabolic pathways were most active in sick or healthy mice. The change
in ratio from carbon-12 to carbon-13 could be measured in minutes within the
carbon dioxide exhaled by the mice.
Researchers were able to identify similar patterns using
two independent assays. The study used nuclear magnetic resonance spectroscopy
on blood serum and cavity ring-down spectroscopy on exhaled breath. These
techniques were sensitive enough to detect a statistically significant
difference between even small populations of healthy and sick mice. Currently,
the cavity ring-down spectroscopy analysis uses a machine about the size of a
shoebox, but a company called Isomark, LLC (co-founded by the researchers) is
developing a hand-held "breathalyzer" that could be taken into rural or remote
areas.
Take a Deep Breath
The new research shows that these biochemical changes can
be detected much sooner than typical symptoms would appear- even within a few
hours- offering hope of early disease detection and diagnosis. Another
advantage of the breathalyzer is that it surveys the workings of the entire
body with a single test and could provide almost immediate feedback on the
effectiveness of treatments. "It's a cheaper, faster, and more sensitive
method of diagnosis" says Porter.
There is currently a project underway called The Human Metabolome Project tasked with
identifying and classifying every human metabolite, much like the
classification of the human genome. Results have been promising and the more
metabolites that are classified, the more scientists and doctors will be able
to use the information to develop diagnostic tests for a wide range of
diseases.
Resources
Metabolic
"breathalyzer" reveals early signs of disease
|